Patent intelligence · US
US 6864350
Soluble, degradable poly (ethylene glycol) derivatives for controllable release of bound molecules into solution
Soluble, degradable poly (ethylene glycol) derivatives for controllable release of bound molecules into solution
Patent details — US 6864350
- Jurisdiction
- US
- Status
- expired
- Grant date
- Mar 8, 2005
- Expiration
- Mar 3, 2025
- Applicant
- Nektar Therapeutics AL, Corporation
- Claims
- 44
- CPC classes
- A61K, A61K47/60
Quick answer
US 6864350 (Soluble, degradable poly (ethylene glycol) derivatives for controllable release of bound molecules into solution) is held by Nektar Therapeutics AL, Corporation. Status: expired. Granted Mar 8, 2005. Expires Mar 3, 2025 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Nektar Therapeutics AL, Corporation
- Grant date
- Expiration
- Claims
- 44
- CPC classes
- A61K, A61K47/60
More from Nektar Therapeutics AL, Corporation
Related pharmaceutical patents in our USPTO index.
-
US 12324828
Conjugates of a factor VIII moiety having an oxime-containing linkage
granted -
US 12325708
Adenosine 2 receptor antagonists
granted -
US 12247059
Conjugates of an IL-2 moiety and a polymer
granted -
US 12233104
Combination of an IL-2RBETA-selective agonist and a long-acting IL-15 agonist
granted -
US 12214045
Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeutic treatment methods
granted -
US 12054553
Immunotherapeutic tumor treatment method
granted -
US 12036283
Long-acting interleukin-15 receptor agonists and related immunotherapeutic compositions and methods
granted -
US 12030940
Immunotherapeutic tumor treatment method
granted
Related coverage
BBSW AI Solution: Key Insights from the 2026 Event
The BBSW AI Solution event in Foster, USA, promises to unveil critical advancements in AI technology for the pharma industry. Stay tuned for live updates and key takeaways.
BBSW AI Solution 2026: Key Insights and Highlights
The BBSW AI Solution event in 2026 is set to unveil groundbreaking advancements in AI technology. Join us for live coverage and key insights from industry leaders.
Frequently asked questions
What is US patent 6864350?
US 6864350 (Soluble, degradable poly (ethylene glycol) derivatives for controllable release of bound molecules into solution) is held by Nektar Therapeutics AL, Corporation. Status: expired. Granted Mar 8, 2005. Expires Mar 3, 2025 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 6864350?
Nektar Therapeutics AL, Corporation is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 423 pharmaceutical patents for this assignee.
When does US 6864350 expire?
Our index shows an expiration date of Mar 3, 2025 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.